This opportunity funds projects developing clinically validated predictive biomarkers for chronic non-communicable diseases (excluding cancer) using AI methodologies. It supports multidisciplinary collaborations combining clinical, longitudinal, and real-world data to enhance personalised medicine, clinical research, and healthcare outcomes. The goal is to provide clinicians with trustworthy AI tools and improve health outcomes through biomarker-guided interventions.
Eligible applicants include legal entities from eligible countries as described in the Horizon Europe Work Programme General Annexes, including the US. Proposals must comply with admissibility conditions such as blind evaluation requirements and page limits. Specific eligibility details are in the H
